Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 558Carcinoma, Non-Small-Cell Lung 510Prostatic Neoplasms 333Neoplasms 271Colorectal Neoplasms 271Multiple Myeloma 268Leukemia, Myeloid, Acute 225Squamous Cell Carcinoma of Head and Neck 217Lung Neoplasms 210Neoplasm Metastasis 205Carcinoma, Hepatocellular 197Melanoma 175Triple Negative Breast Neoplasms 173Pancreatic Neoplasms 171Recurrence 151Ovarian Neoplasms 151Lymphoma 142Glioblastoma 136Brain Neoplasms 133Sarcoma 129Leukemia, Lymphocytic, Chronic, B-Cell 127Carcinoma, Renal Cell 127Lymphoma, Large B-Cell, Diffuse 126Stomach Neoplasms 123Head and Neck Neoplasms 123Precursor Cell Lymphoblastic Leukemia-Lymphoma 111Rectal Neoplasms 108Myelodysplastic Syndromes 105Urinary Bladder Neoplasms 100Small Cell Lung Carcinoma 98

Interventions

dehydroftorafur 1Taxes 1Ramucirumab 1Paclitaxel 1Leucovorin 1Irinotecan 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Metastatic Small Intestinal Adenocarcinoma × 1 year × Clear all
NCT04205968 2025-11-05

Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

SWOG Cancer Research Network

Phase 2 Recruiting
94 enrolled

Metastatic Small Intestinal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡